The FDA has issued clear signals on BPC 157: it is not approved for human use in any form due to potential significant safety risks. This critical classification profoundly impacts research and FDA Targets GLP 1 and Peptide Compounding, Advertising and 'Research Use Only' Labeling FDA moves toward easing restrictions on certain peptides BioPharma Dive Early evidence suggests BPC 157 repairs tissue rather than just dulling symptoms. To read more, tap the link in bio.